Search

A recent study conducted at Brigham and Women's Hospital in Boston, Massachusetts, explores the role of dendritic cells (DCs) in autoimmune disorders. The researchers identified a regulatory loop in DCs that limits immunopathology and developed a synthetic probiotic that activates this pathway for therapeutic purposes. The study highlights the potential of targeting DCs for the treatment of autoimmune diseases. The research was funded by various organizations, including the National Institutes of Health and the American Cancer Society. [Extracted from the article]

Keywords: Boston; State:Massachusetts; United States; North and Central America; Antigen-Presenting Cells; Autoimmunity; Dendritic Cells; Health and Medicine; Immunology; Mononuclear Phagocyte System EN Boston State:Massachusetts United States North and Central America Antigen-Presenting Cells Autoimmunity Dendritic Cells Health and Medicine Immunology Mononuclear Phagocyte System 630 630 1 09/19/23 20230922 NES 230922 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators discuss new findings in Immunology - Autoimmunity. Boston, State:Massachusetts, United States, North and Central America, Antigen-Presenting Cells, Autoimmunity, Dendritic Cells, Health and Medicine, Immunology, Mononuclear Phagocyte System. [Extracted from the article]